Tesla CEO and technology entrepreneur
Elon Musk
Elon Musk is Tesla's CEO and a technology entrepreneur whose work spans electric vehicles, space technology, and the AI business acquired by SpaceX.
About Elon Musk
Elon Musk is the CEO of Tesla, where he oversees product design, engineering, and manufacturing. He also leads SpaceX and has worked on businesses including Neuralink and The Boring Company.
His business interests intersect with artificial intelligence through SpaceX's AI operations. In February 2026, xAI announced that SpaceX had acquired it. The AI business develops Grok and tools for reasoning, voice interaction, and generative media.
Mentioned in our coverage
127 articles name Elon Musk, excluding author credits.
Page 4 of 11
- The New Twitter Launched — and the Loudest Reply Was About Its Homepage →
Operation Bluebird's twitter.new went live, claiming Musk's X abandoned the Twitter name. The highest-engagement reply to the news wasn't about the lawsuit — it was "the most vibe coded piece of junk homepage I've ever seen." explainx.ai fetched the real site and checked the accusation against the actual copy and markup.
- Felony Bench: The Satirical Leaderboard Hit #1 on Hacker News →
A tongue-in-cheek site called Felony Bench scored Anthropic and OpenAI 8-8 on real, documented incidents where AI agents "inadvertently compromised" third parties — and its Hacker News thread turned into the most substantive public debate yet on who is actually liable when an agentic loop breaks the law.
- grok.bot Wants $1 Million From SpaceXAI. The Registry Record Is Less Cute. →
A landing page at grok.bot is asking SpaceXAI for $1 million, pitching the name as dumb luck bought one month before Grok Bot launched. Public RDAP records show the domain was first registered on January 20, 2026 and transferred on July 27 — two weeks before the August 11 product, not T-1 month. explainx.ai separates the joke from the registry timeline, and what it means if you are about to name an agent product.
- Moderna and Merck's AI-Designed mRNA Cancer Vaccine Just Won Phase 3 →
On August 19, 2026, Moderna and Merck announced that intismeran autogene (formerly mRNA-4157/V940) plus Keytruda met its primary and key secondary endpoints in the Phase 3 INTerpath-001 melanoma trial — the first positive late-stage result for an individualized mRNA cancer therapy. The real story for AI builders isn't the headline; it's the neoantigen-prediction ML pipeline that makes "personalized per patient" a literal, not marketing, claim.
- Stripe Says the Singularity Started January 1 — Here's the Actual Evidence →
Stripe's August 2026 investor letter declares January 1 "the beginning of the singularity" — not Vernor Vinge's unpredictable-superintelligence definition, but an inflection in firm creation. We separate Stripe's own operating stats from the branding exercise, and what the letter actually says about OpenRouter.